Abstract:Cardiovascular diseases plague human health because of the lack of transplantable small-diameter blood vessel (SDBV) grafts. Although expanded polytetrafluoroethylene (ePTFE) has the potential to be used as a biocompatible material for SDBV grafts, long-term patency is still the biggest challenge. As discussed in this paper, by virtue of a novel material formulation and a new and benign alcohol/water lubricating agent, biofunctionalized ePTFE blood vessel grafts aimed at providing long-term patency were fabricated. Compared to the most prevalent modification of PTFE, namely surface treatment, this method realized bulk treatment, which could guarantee homogeneous and long-lasting performance throughout PTFE products. These blood vessel grafts included embedded functional biomolecules, such as arginylglycylaspartic acid, heparin, and selenocystamine, using water as a solvent in paste extrusion and in the expansion of ePTFE. Fourier-transform infrared spectroscopy, X-ray photoelectron spectroscopy, and scanning electron microscope results confirmed the existence of these targeting biomolecules in the as-fabricated ePTFE blood vessel grafts. Meanwhile, the greatly improved biological functions of the grafts were demonstrated <i>via</i> live and dead assays, cell morphology, CD31 staining, nitric oxide (NO) release, and anticoagulation tests. This novel and benign material formulation and fabrication method provides an opportunity to produce multibiofunctional ePTFE blood vessel grafts in a single step, thus yielding a potent product with significant commercial and clinical potential.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.biomac.0c00897?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biomac.0c00897</a>.SEM of ePTFE fabricated by using naphtha as lubricants; SEM of ePTFE with different expanded ratios; XPS survey scans of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA; fluorescence images of HCAECs cultured on different grafts for 4 h; fluorescence images of HCAECs cultured on ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA grafts for 10 days, respectively; immunochemical staining of HCAECs incubated on neat ePTFE and biofunctionalized ePTFE grafts; and element percentage results of ePTFE, ePTFE-RGD, ePTFE-heparin, and ePTFE-SeCA (<a class="ext-link" href="/doi/suppl/10.1021/acs.biomac.0c00897/suppl_file/bm0c00897_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Klotho functionalization on vascular graft for improved patency and endothelialization

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Development of Small-Diameter Artificial Vascular Grafts Using Transgenic Silk Fibroin

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Enhancing small diameter tissue engineered vascular grafts with heparin and hepatocyte growth factor: A promising approach

Fabrication of heparinized small diameter TPU/PCL bi-layered artificial blood vessels and in vivo assessment in a rabbit carotid artery replacement model

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Expanded polytetrafluoroethylene/silk fibroin/salicin vascular graft fabrication for improved endothelialization and anticoagulation

Construction and performance evaluation of Hep/silk-PLCL composite nanofiber small-caliber artificial blood vessel graft

A Method for Preparation of an Internal Layer of Artificial Vascular Graft Co-Modified with Salvianolic Acid B and Heparin

Functionalization of in Vivo Tissue-Engineered Living Biotubes Enhance Patency and Endothelization Without the Requirement of Systemic Anticoagulant Administration.

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H2S for Anti-Inflammation and Anticalcification

Construction of Enzyme-Laden Vascular Scaffolds Based on Hyaluronic Acid Oligosaccharides-Modified Collagen Nanofibers for Antithrombosis and In-Situ Endothelialization of Tissue-Engineered Blood Vessels.

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Impaired endothelial cell proliferative, migratory, and adhesive abilities are associated with the slow endothelialization of polycaprolactone vascular grafts implanted into a hypercholesterolemia rat model

Fabrication of small-diameter in situ tissue engineered vascular grafts with core/shell fibrous structure and a one-year evaluation via rat abdominal vessel replacement model

Scaffold Engineering with Flavone-Modified Biomimetic Architecture for Vascular Tissue Engineering Applications

Improving Vascular Regeneration Performance of Electrospun Poly(ε-Caprolactone) Vascular Grafts via Synergistic Functionalization with VE-Cadherin/VEGF

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

Effect of Resveratrol on Modulation of Endothelial Cells and Macrophages for Rapid Vascular Regeneration from Electrospun Poly(ε-caprolactone) Scaffolds.

Biologically Functionalized Expanded Polytetrafluoroethylene Blood Vessel Grafts